Palladyne AI Just Became America's Loitering Munitions Manufacturer
A ~$280M market-cap defense tech firm just landed exclusive U.S. rights to manufacture and sell Israel's combat-proven HARPY, HAROP, and Mini HARPY loitering munitions to the Department of War. Revenue is already up 107% year over year — this is a micro-cap with a real order book, not a story stock.
Palladyne AI Corp. (Nasdaq: PDYN), a Salt Lake City-based autonomy and robotics company trading around a $280 million market cap, just announced something most micro-caps never get close to: exclusive U.S. rights to manufacture, integrate, and market a family of combat-proven weapons systems to the Department of War. The partner is Israel Aerospace Industries (IAI), and the systems are the HARPY, HAROP, and Mini HARPY — loitering munitions with more than 40 years of real-world deployment history across militaries worldwide.
What's actually changing hands. Under the partnership, Palladyne AI will adapt IAI's systems to U.S. operational requirements and domestically manufacture the components and subsystems, while IAI supplies engineering support and key subsystems from its four-decade track record. In plain terms: instead of the Pentagon waiting years for a clean-sheet domestic loitering munitions program, it can get combat-validated Israeli technology built on American soil, faster. IAI's Chairman Boaz Levy called it "a significant step in expanding our long-term presence and industrial cooperation in the U.S. defense sector," while Palladyne AI CEO Ben Wolff was blunter about the strategic logic: "The U.S. defense industrial base needs battle-proven loitering munitions capabilities it can field now... This partnership is the first major proof of what it can do."
Why this isn't just a press-release pop. Loitering munitions — autonomous systems that search for, identify, and strike hostile targets like radar sites and command-and-control centers — are exactly the capability category the Department of War has been directing new budget toward as it modernizes for contested, multi-domain environments. This isn't Palladyne's first defense relationship, either: the company has also demonstrated autonomous swarming capability through its IntelliSwarm and SwarmOS platforms and added retired senior military leadership, including Admiral Eric T. Olson, to its board. The numbers back up the narrative — Palladyne AI posted 107% year-over-year revenue growth last quarter and has reaffirmed its full-year guidance, a real, growing top line underneath the contract headlines.
The risk side of the ledger. This is a manufacturing and integration partnership formalized via a memorandum of understanding, not yet a signed, funded Department of War production contract — the government still has to actually buy the systems at scale for this to translate into revenue. Palladyne is also not the only small-cap chasing the defense-AI narrative; peers like BigBear.ai and Ondas are pursuing overlapping government opportunities, and budget cycles, appropriations delays, and program cancellations are permanent risks in this sector regardless of how strong any single partnership looks on paper.
What separates this from a lot of the "AI defense" story stocks flooding the micro-cap tape is specificity: a named partner with 40 years of combat deployment, a defined product family, and real production commitments domestically — not just a slide deck about the addressable market. Whether Palladyne converts this MoU into actual, recognized production revenue over the next few quarters is the metric worth tracking, not the headline itself.
| 📊 Scoring Guide | |
|---|---|
| Asset Quality / Execution (1–10) | Measures tangible, verifiable fundamentals — revenue growth, profitability, contracts, institutional backing, and proprietary technology. A higher score indicates a company with real, derisked business performance. |
| Promotion Intensity (1–10) | Measures the volume of investor relations marketing, press release cadence, retail buzz, and promotional activity relative to actual operational progress. A higher score indicates more hype relative to substance. |
| Market Leader / Catalyst Play | High asset quality + High promotion. Real business with active market attention. |
| Hidden Value / Deep Value | High asset quality + Low promotion. Overlooked company with solid fundamentals. |
| Pure Promote / Pump Risk | Low asset quality + High promotion. Heavy promotion with limited operational substance. |
| Zombie Stock / Dormant | Low asset quality + Low promotion. Limited activity and minimal market interest. |
This article is for informational purposes only and does not constitute investment advice.
Todd Colpron is the Managing Partner of Eliakim Capital, a private investment and strategic advisory firm that manages its own capital while working alongside select family offices and private investors to identify and support exceptional opportunities.
Important Disclosure and Disclaimer
This publication is provided solely for general educational and informational purposes. Nothing contained in this publication constitutes, or should be construed as, investment, financial, legal, accounting, or tax advice; a recommendation or endorsement of any security, issuer, transaction, or investment strategy; or personalized advice based on any reader's particular financial circumstances.
This publication does not constitute an offer to sell, a solicitation of an offer to buy, or an invitation to enter into any transaction involving securities. Any offer or sale of securities may be made only through applicable offering documents and in accordance with applicable federal and state securities laws.
The Daily MicroCap and Eliakim Capital are not registered broker-dealers and do not execute securities transactions, accept investor funds, or provide brokerage services. Unless separately and expressly disclosed, neither The Daily MicroCap nor Eliakim Capital is acting as an investment adviser to any reader, and no advisory, fiduciary, attorney-client, or other professional relationship is created by this publication.
Information contained herein may be obtained from issuers, public filings, press releases, third-party sources, or other materials believed to be reliable; however, its accuracy, completeness, timeliness, and reliability are not guaranteed, and the information may not have been independently verified. Opinions and estimates are made as of the publication date and may change without notice.
Any statements regarding anticipated events, business prospects, financial performance, valuation, market opportunities, or future results are forward-looking and inherently uncertain. Actual outcomes may differ materially due to known and unknown risks.
Microcap and emerging-company securities can be highly speculative, volatile, illiquid, and subject to substantial dilution, limited publicly available information, and the risk of a complete loss of invested capital. Readers must conduct their own independent investigation and consult appropriately licensed financial, legal, and tax professionals before making any investment decision.
Neither The Daily MicroCap nor Eliakim Capital received compensation from the issuer for preparing or distributing this article.
Past performance is not indicative of future results. No representation or warranty is made regarding any investment outcome.